QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
QQQ   414.73 (-2.05%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   146.98 (-1.97%)
NVDA   769.00 (-9.18%)
AMD   146.18 (-5.74%)
NIO   3.81 (-4.75%)
BABA   69.05 (+0.25%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   106.48 (-4.87%)
GE   148.44 (-2.94%)
CGC   8.05 (+2.81%)
DIS   112.31 (-0.11%)
AMC   3.13 (+7.19%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.97 (+1.22%)
Free Trial
NASDAQ:KIN

Kindred Biosciences (KIN) Stock Price, News & Analysis

→ Your Money is Not Safe (From American Alternative) (Ad)
Free KIN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$9.24
▼
$9.26
50-Day Range
$9.08
▼
$9.25
52-Week Range
$3.46
▼
$9.28
Volume
178,496 shs
Average Volume
840,890 shs
Market Capitalization
$420.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
KIN stock logo

About Kindred Biosciences Stock (NASDAQ:KIN)

Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.

KIN Stock News Headlines

March 22, 2024 | mirror.co.uk
Tory party donor Frank Hester to be investigated for 'racist comments' by West Yorkshire Police
February 23, 2024 | health.usnews.com
Kindred Hospital East Greensboro
April 19, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
January 22, 2024 | reuters.com
Japan's Sony terminates $10 bln Zee India merger
January 22, 2024 | markets.businessinsider.com
European Shares Edge Higher With ECB Meeting In The Spotlight
January 22, 2024 | markets.businessinsider.com
Earnings Optimism May Contribute To Continued Strength On Wall Street
December 17, 2023 | latimes.com
Honoree: Nanxi Liu
November 8, 2023 | finance.yahoo.com
Global Companion Animal Pharmaceuticals Market Size To Worth USD 27.16 Billion by 2032 | CAGR of 5.7%
April 19, 2024 | Crypto Swap Profits (Ad)
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
October 7, 2023 | health.usnews.com
Kindred Hospital-Dayton
September 21, 2023 | tmcnet.com
Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development
August 17, 2023 | bizjournals.com
How a small Peninsula company plans to take a big bite out of the pet drug market
June 11, 2023 | es-us.finanzas.yahoo.com
Pet Cancer Therapeutics Global Market Report 2023
May 11, 2023 | marketwatch.com
Oral COVID-19 Vaccine Market 2023 Expected Highest Growth and Precise Outlook | Pfizer, CanSino Biologics, Kindred Biosciences
May 5, 2023 | marketwatch.com
Pet Medication Market Size and Forecast to 2031
May 5, 2023 | health.usnews.com
Kindred Hospital-New Jersey Morris County
April 26, 2023 | uk.finance.yahoo.com
Veterinary Dermatology Drugs Global Market Report 2023
April 25, 2023 | health.usnews.com
Kindred Hospital Chicago-Northlake
April 19, 2023 | usnews.com
Kindred High School
April 19, 2023 | thestreet.com
Kindred Bio CEO: Expect 3 Dynamic Dog Drugs by 2015
March 31, 2023 | theguardian.com
Kindred review – a reductive, hollow view of Black trauma
March 30, 2023 | marketwatch.com
Canine Atopic Dermatitis Market Share and Forecast till 2031
March 28, 2023 | health.usnews.com
Kindred Hospital-Ontario
March 22, 2023 | marketwatch.com
Companion Animal Pharmaceuticals Market worth $19.6 billion | MarketsandMarkets
March 7, 2023 | marketwatch.com
The Pet Medication study examines a number of direct and indirect factors that could affect the supply and demand dynamics in this market
March 6, 2023 | msn.com
How De La Soul's 3 Feet High and Rising broadened the possibilities of hip hop
March 3, 2023 | marketwatch.com
Pet Medication Market 2023 | Global Industry Report Forecast 2029
See More Headlines
Receive KIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kindred Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/05/2021
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KIN
CUSIP
N/A
CIK
1561743
Web
kindredbio.com
Phone
(650) 701-7901
Fax
N/A
Employees
63
Year Founded
2013

Profitability

EPS (Most Recent Fiscal Year)
($0.55)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-21,800,000.00
Net Margins
-529.26%
Pretax Margin
N/A
Return on Equity
-54.19%
Return on Assets
-39.76%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
7.02
Quick Ratio
7.02

Sales & Book Value

Annual Sales
$42.16 million
Price / Sales
9.97
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.75 per share
Price / Book
5.29

Miscellaneous

Outstanding Shares
45,462,000
Free Float
N/A
Market Cap
$420.52 million
Optionable
Optionable
Beta
1.30

Social Links

7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Key Competitors

View All Competitors

KIN Stock Analysis - Frequently Asked Questions

How were Kindred Biosciences' earnings last quarter?

Kindred Biosciences, Inc. (NASDAQ:KIN) issued its quarterly earnings data on Thursday, August, 5th. The biopharmaceutical company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.04. The biopharmaceutical company earned $3.54 million during the quarter, compared to analyst estimates of $8.12 million. Kindred Biosciences had a negative trailing twelve-month return on equity of 54.19% and a negative net margin of 529.26%.

What other stocks do shareholders of Kindred Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kindred Biosciences investors own include bluebird bio (BLUE), Sorrento Therapeutics (SRNE), Amicus Therapeutics (FOLD), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Inovio Pharmaceuticals (INO), OPKO Health (OPK), TherapeuticsMD (TXMD) and Agile Therapeutics (AGRX).

This page (NASDAQ:KIN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends